439 related articles for article (PubMed ID: 27378009)
21. Decreasing catheter-related infection and hospital costs by continuous quality improvement.
Civetta JM; Hudson-Civetta J; Ball S
Crit Care Med; 1996 Oct; 24(10):1660-5. PubMed ID: 8874302
[TBL] [Abstract][Full Text] [Related]
22. Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis.
Wei L; Li Y; Li X; Bian L; Wen Z; Li M
BMC Infect Dis; 2019 May; 19(1):429. PubMed ID: 31096918
[TBL] [Abstract][Full Text] [Related]
23. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.
Ostendorf T; Meinhold A; Harter C; Salwender H; Egerer G; Geiss HK; Ho AD; Goldschmidt H
Support Care Cancer; 2005 Dec; 13(12):993-1000. PubMed ID: 15834740
[TBL] [Abstract][Full Text] [Related]
24. Maintenance antisepsis in reducing the rate of late-onset central venous catheter-related bloodstream infection: A comparison of 0.05% and 1% chlorhexidine.
Kikuchi M; Sato T; Okada S; Abe N; Sato A; Suzuki Y
J Infect Chemother; 2020 Feb; 26(2):188-193. PubMed ID: 31495567
[TBL] [Abstract][Full Text] [Related]
25. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
[TBL] [Abstract][Full Text] [Related]
26. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
[TBL] [Abstract][Full Text] [Related]
27. The safety of prolonging the use of central venous catheters: a prospective analysis of the effects of using antiseptic-bonded catheters with daily site care.
Norwood S; Wilkins HE; Vallina VL; Fernandez LG; McLarty JW
Crit Care Med; 2000 May; 28(5):1376-82. PubMed ID: 10834681
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
Rosato AE; Tallent SM; Edmond MB; Bearman GM
Am J Infect Control; 2004 Dec; 32(8):486-8. PubMed ID: 15573055
[No Abstract] [Full Text] [Related]
31. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
[TBL] [Abstract][Full Text] [Related]
32. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.
Brun-Buisson C; Doyon F; Sollet JP; Cochard JF; Cohen Y; Nitenberg G
Intensive Care Med; 2004 May; 30(5):837-43. PubMed ID: 15060765
[TBL] [Abstract][Full Text] [Related]
33. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
[TBL] [Abstract][Full Text] [Related]
34. New choices for central venous catheters: potential financial implications.
Shorr AF; Humphreys CW; Helman DL
Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial-impregnated catheters for the prevention of catheter-related bloodstream infections.
Lorente L
World J Crit Care Med; 2016 May; 5(2):137-42. PubMed ID: 27152256
[TBL] [Abstract][Full Text] [Related]
36. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
[TBL] [Abstract][Full Text] [Related]
38. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
39. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
[TBL] [Abstract][Full Text] [Related]
40. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria.
Schmitt SK; Knapp C; Hall GS; Longworth DL; McMahon JT; Washington JA
J Clin Microbiol; 1996 Mar; 34(3):508-11. PubMed ID: 8904403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
